Page 530«..1020..529530531532..540550..»

Global Mesenchymal Stem Cells Market Analysis, Opportunities, Trend and Forecast To 2029 Discovery Sports Media – Discovery Sports Media

Posted: January 20, 2022 at 2:30 am

The Global Mesenchymal Stem Cells Market Report by QY Reports is a meticulously undertaken study. Experts with proven credentials and a high standing within the research fraternity have presented an in-depth analysis of the subject matter, bringing to bear their unparalleled domain knowledge and vast research experience. They offer some penetrating insights into the complex world of Mesenchymal Stem Cells Market Industry. Their sweeping overview, comprehensive analyses, precise definitions, clear classifications, and expert opinions on applications, make this report nothing short of brilliant in its presentation and style.

Key Players Influencing the Mesenchymal Stem Cells Market:

Lonza

Thermo Fisher

Bio-Techne

ATCC

MilliporeSigma

PromoCell GmbH

Genlantis

Celprogen

Cell Applications

Cyagen Biosciences

Axol Bioscience

Download PDF Sample Copy of this Report: https://www.qyreports.com/request-sample/?report-id=321253

The documented report aims to offer an organized and methodical strategy for important aspects that have affected the market in recent years and future market opportunities that companies can trust. It gives readers clear market research for better judgment and better decision making on whether or not to invest. The report provides an analysis and overview of the future dynamics with an in-depth analysis of the most important players that are likely to contribute to the growth of the global Mesenchymal Stem Cells market during the forecast period.

The market report also provides a correct assessment of the company strategies and business models that companies implement to stay in the market and lead. Some of the most important steps companies are taking are mergers and acquisitions, partnerships and collaborations to expand their regional and global reach. In addition, the players are also launching a new range of products to enrich their portfolio by using the latest technology and implementing them in their company.

The report is updated with the impact of the currently unfoldingCOVID-19pandemic. The pandemic has dynamically affected the key segments of the market and has changed the growth pattern and demands in the Mesenchymal Stem Cells Market. The report covers extensive analysis of these changes and provides an accurate forecast estimation of the market growth after the impact of the pandemic.

Mesenchymal Stem Cells Market Segmentation:

The report has classified the market into segments including product type, and application. Every segment is evaluated based on share and growth rate. Besides, the analysts have studied the potential regions that may prove rewarding for the manufacturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall industry.

Ask for Discount on this Premium Report: https://www.qyreports.com/ask-for-discount/?report-id=321253

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global Mesenchymal Stem Cells market based on the type and application. It also provides market size and forecast till 2028 for overall Mesenchymal Stem Cells market with respect to five major regions, namely; North America, Europe, Asia-Pacific, Middle East and Africa and South America. The market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast globally along with the current trends and opportunities prevailing in the region.

Why the Mesenchymal Stem Cells Market Report is Beneficial?

If You Have Any Query/Inquiry, Ask Our Expert: https://www.qyreports.com/enquiry-before-buying/?report-id=321253

Major Highlights of the Report:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team, who will ensure that you get a report that suits your needs.

Seeking to initiate a fruitful business relationship with you!

About Us

We at QYReports, a leading market research report publisher cater to more than 4,000 prestigious clients worldwide meeting their customized research requirements in terms of market data size and its application. Our list of customers include renouned Chinese companies multinational companies, SMEs and private equity firms. our business study covers a market size of over 30 industries offering you accurate, in depth and reliable market insight, industry analysis and structure. QYReports specialize in forecasts needed for investing in an and execution of a new project globally and in Chinese markets.

Contact Us:

Name: Jones John

Contact number: +1-510-560-6005

204, ProfessionalCenter,

7950 NW 53rd Street, Miami, Florida 33166

sales@qyreports.com

http://www.qyreports.com

Read the rest here:
Global Mesenchymal Stem Cells Market Analysis, Opportunities, Trend and Forecast To 2029 Discovery Sports Media - Discovery Sports Media

Posted in Florida Stem Cells | Comments Off on Global Mesenchymal Stem Cells Market Analysis, Opportunities, Trend and Forecast To 2029 Discovery Sports Media – Discovery Sports Media

Limitless TRT and Aesthetics is the New Testosterone Replacement Therapy Clinic in Gilbert Arizona – Digital Journal

Posted: January 20, 2022 at 2:25 am

Gilbert, AZ Limitless TRT and Aesthetics is addressing one of the most common problems affecting men of all ages. The providers at the new mens health clinic are focused on working closely with men to restore their strength, function, and ability to engage in certain activities that may have been lost due to age. Through their proven and effective treatment solutions, including testosterone replacement therapy, they have been able to address common problems like erectile dysfunction, loss of strength and muscle mass, and others.

At Limitless TRT & Aesthetics, we dont give up on men as they age. In fact, its just the opposite. We think men can get even better as the years go by as long as they pay attention to their health and take action when necessary. The word limitless is in our name for a reason there is no limit to what a man can accomplish, and its our purpose to help men push their boundaries and make their vision for life a reality, said the companys spokesperson.

To help more men live a full life that they love, the mens health clinic offers a variety of services and treatments that are based on the specific complaints of each patient. Each patient will have access to personalized care and treatment that begins with an initial consultation and comprehensive assessment of their health. As great listeners, the providers will listen closely to each patients complaints, assess them comprehensively, and determine the next line of action regarding treatment.

Added to Testosterone Replacement Therapy, they also offer Focused Shockwave therapy, a non-invasive treatment procedure that addresses a variety of physical issues including erectile dysfunction, pain and discomfort, etc. As a focused mens health clinic, Limitless TRT and Aesthetics further provides aesthetic treatments and services to help men look their best, irrespective of their age. Some of the aesthetic procedures offered include CO2 Laser Resurfacing to address all kinds of skin blemishes and problems, including lost skin tone, target lines on the skin, etc.

Men can also take advantage of the non-invasive cryolypolisis service offered to address excess fat deposits in areas like the underarm, stomach, thighs, and other areas. They also offer botulinum toxin type A treatments, facial fillers, electro muscle stimulation sculpting, and concierge medicine services.

Men who wish to take control of their health, appearance, and wellness can contact Limitless TRT and Aesthetics via phone at 1-480-400-0105, or visit them at 3483 S Mercy Rd Suite 104, Gilbert, Arizona 85297, US. For more information, visit their website.

Media Contact

Company NameLimitless TRT and AestheticsContact NameJosh LeimbachPhone1-480-400-0105Address3483 S Mercy Rd Suite 104CityGilbertStateArizonaPostal Code85297CountryUnited StatesWebsitehttps://limitlesstrtandaesthetics.com/

See the rest here:
Limitless TRT and Aesthetics is the New Testosterone Replacement Therapy Clinic in Gilbert Arizona - Digital Journal

Posted in Testosterone Replacement Therapy | Comments Off on Limitless TRT and Aesthetics is the New Testosterone Replacement Therapy Clinic in Gilbert Arizona – Digital Journal

UV Radiation and the Skin – PubMed Central (PMC)

Posted: January 20, 2022 at 2:24 am

Int J Mol Sci. 2013 Jun; 14(6): 1222212248.

1Graduate Center for Toxicology and the Departments of Pediatrics, Biomedical and Molecular Pharmacology and Physiology, Markey Cancer Center, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA

2Markey Cancer Center, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA; E-Mail: ude.yku@tterraj.trauts

3Graduate Center for Toxicology, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA; E-Mail: ude.yku@2amlaa (A.A.-O.); ude.yku@ttocs.mit (T.S.)

3Graduate Center for Toxicology, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA; E-Mail: ude.yku@2amlaa (A.A.-O.); ude.yku@ttocs.mit (T.S.)

1Graduate Center for Toxicology and the Departments of Pediatrics, Biomedical and Molecular Pharmacology and Physiology, Markey Cancer Center, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA

Received 2013 Apr 25; Revised 2013 May 18; Accepted 2013 May 24.

UV radiation (UV) is classified as a complete carcinogen because it is both a mutagen and a non-specific damaging agent and has properties of both a tumor initiator and a tumor promoter. In environmental abundance, UV is the most important modifiable risk factor for skin cancer and many other environmentally-influenced skin disorders. However, UV also benefits human health by mediating natural synthesis of vitamin D and endorphins in the skin, therefore UV has complex and mixed effects on human health. Nonetheless, excessive exposure to UV carries profound health risks, including atrophy, pigmentary changes, wrinkling and malignancy. UV is epidemiologically and molecularly linked to the three most common types of skin cancer, basal cell carcinoma, squamous cell carcinoma and malignant melanoma, which together affect more than a million Americans annually. Genetic factors also influence risk of UV-mediated skin disease. Polymorphisms of the melanocortin 1 receptor (MC1R) gene, in particular, correlate with fairness of skin, UV sensitivity, and enhanced cancer risk. We are interested in developing UV-protective approaches based on a detailed understanding of molecular events that occur after UV exposure, focusing particularly on epidermal melanization and the role of the MC1R in genome maintenance.

Keywords: Ultraviolet radiation, skin, carcinogenesis, mutagenesis, pigmentation, cancer, melanin, melanocortin 1 receptor

Comprising roughly 16% of body mass, the skin is the largest organ of the body. Skin is organized into two primary layers, epidermis and dermis, which together are made up of epithelial, mesenchymal, glandular and neurovascular components. The epidermis, of ectodermal origin, is the outermost layer and serves as the bodys point of contact with the environment. As such, epidermal biological and physical characteristics play an enormous role in resistance to environmental stressors such as infectious pathogens, chemical agents and UV [16]. Keratinocytes are the most abundant cells in the epidermis and are characterized by their expression of cytokeratins and formation of desmosomes and tight junctions with each other to form an effective physicochemical barrier. The dermis, derived from mesoderm, underlies the epidermis and harbors cutaneous structures including hair follicles, nerves, sebaceous glands and sweat glands. The dermis also contains abundant immune cells and fibroblasts, which actively participate in many physiologic responses in the skin. The epidermis, demarcated from the dermis by a basement membrane, is organized into functional layers defined largely by keratinocyte characteristics such as size, shape, nucleation and keratin expression [7] (). Nascent epidermal keratinocytes formed as a result of cell division by keratinocyte stem cells in the stratum basale undergo a programmed differentiation as they migrate outward toward the surface of the skin to eventually form corneocytes, which are tightly-linked dead but intact cells that form the principle barrier of the outermost epidermal layer [8,9].

Epidermal structure and keratinocyte differentiation. The epidermis is a self-renewing tissue composed mainly of keratinocytes in various stages of terminal differentiation. Keratinocytes are produced in the stratum basale (basal layer), and move outward through the epidermis, undergoing a programmed series of differentiation involving enucleation and accumulation of cytokeratins and tight junctions with each other. Keratinocytes also receive melanin from melanocytes in the form of pre-packaged organelles termed melanosomes. The basic layers from the basement membrane outward are the stratum basale, stratum spinosum, stratum granulosum, and the stratum corneum, each identified by the morphology and differentiation state of the keratinocyte as indicated by expression of cytokeratins and other proteins.

Besides the creation of a highly effective physical barrier, keratinocytes also accumulate melanin pigments as they mature, and epidermal melanin functions to potently block UV penetration into the skin. Although melanin may be found in abundance in epidermal keratinocytes, it is not manufactured in these cells. Rather, melanin synthesis is restricted to melanocytes, which are derived from neural crest and are the second most abundant cell in the epidermis [10,11]. In fact, melanocytes can be found both in the dermis and epidermis. Epidermal melanocytes are generally positioned in the basal layer above the basement membrane. Melanocytes are also found in hair follicles to impart pigment to nascent hair [12]. Dermal melanocytes can be found in nevi (moles). Because melanocytes are the only source of pigment in the skin, inherited pigmentary defects such as albinism tend to be caused by melanocytic genetic defects [10,13]. Through dendritic extensions, melanocytes may be in intimate contact with as many as fifty neighboring keratinocytes in what is known as an epidermal melanin unit [11,14]. There are many contact-dependent and paracrine interactions that occur between keratinocytes and melanocytes in the epidermal melanin unit. Pigment made by melanocytes is transferred to adjacent keratinocytes in cellular organelles termed melanosomes by way of melanocytic dendrites [1517]. In fact, most of the melanin in the skin is found in keratinocytes where it accumulates to function as a natural sunscreen to protect the skin against incoming UV photons. Besides blocking UV penetration into the skin, melanin may have many other important physiologic effects including regulatory influences over epidermal homeostasis, free radical scavenging to protect against oxidative injury, and possibly even antimicrobial activity [10,1824].

The amount and type of epidermal melanin is the main factor that determines skin complexion and UV sensitivity. Melanin is a large bio-aggregate composed of subunits of different pigment species formed by oxidation and cyclization of the amino acid tyrosine [10,25,26] (). Intriguingly, the intermediates of melanogenesis may have important regulatory roles in the skin [2729]. Melanin exists in two main chemical forms: (1) eumelanin, a dark pigment expressed abundantly in the skin of heavily pigmented individuals, and (2) pheomelanin, a light-colored sulfated pigment resulting from incorporation of cysteines into melanin precursors [30]. Eumelanin is much more efficient at blocking UV photons than pheomelanin, thus the more eumelanin in the skin, the less UV-permeable is the epidermis [31]. Fair-skinned people who are almost always UV-sensitive and have high risk of skin cancer have little epidermal eumelanin and therefore realize much more UV than darker-skinned individuals. Therefore, the fairer the skin, the more damaging UV exposure will be. In fact, pheomelanin levels are similar between dark-skinned and light-skinned individuals, and it is the amount of epidermal eumelanin that determines skin complexion, UV sensitivity and cancer risk. Data suggest that pheomelanin may promote oxidative DNA injury and melanomagenesis by generating free radicals in melanocytes even in the absence of UV [3237].

Melanin Biosynthesis. Melanin, a large bioaggregate composed of pigmented chemical species, is found in two major forms: the brown/black highly UV-protective eumelanin pigment and the red/blonde UV-permeable pheomelanin. Both eumelanin and pheomelanin are derived from the amino acid tyrosine. Tyrosinase is the enzyme that catalyzes the rate-limiting synthetic reaction for both melanin species and when defective causes albinism. Incorporation of cysteine into pheomelanin results in the retention of sulfur into the pigment, which yields a light color to the final melanin product and may contribute to oxidative injury in the skin. The melanocyte stimulating hormone (MSH)melanocortin 1 receptor (MC1R) signaling axis is a major determinant of the type and amount of melanin produced by melanocytes in the skin.

Skin complexion is among the most important determinants of UV sensitivity and skin cancer risk. The Fitzpatrick Scale is a semi-quantitative scale made up of six phototypes that describe skin color by basal complexion, melanin level, inflammatory response to UV and cancer risk [13] (). Minimal erythematous dose (MED) is a quantitative method to report the amount of UV (particularly UVB) needed to induce sunburn in the skin 2448 h after exposure by determining erythema (redness) and edema (swelling) as endpoints. The fairer the skin, the easier it is for UV to cause inflammation (sunburn). MED, therefore is highest in dark-skinned persons since more UV radiation is needed to burn eumelanin-rich skin [3840]. In contrast, fair-skinned people whose skin expresses predominantly pheomelanin have low MEDs. Low Fitzpatrick phototype correlates with both MED and with melanoma and other skin cancer risk [41].

Skin pigmentation, the Fitzpatrick scale and UV risk.

Abundant in the environment, UV contributes to a variety of skin maladies including inflammation, degenerative aging and cancer [1]. Historically, humans have been exposed to UV radiation mainly through occupational exposure to sunlight. Recreational UV exposure, however, has increased dramatically in recent years because of outdoor leisure activities and to purposely tan for cosmetic purposes [42,43]. Being a component of the electromagnetic spectrum, UV photons fall between the wavelengths of visible light and gamma radiation. UV energy can be subdivided into UV-A, -B and -C components based on electro physical properties, with UV-C photons having the shortest wavelengths (100280 nm) and highest energy, UV-A having the longest (315400 nm) but least energetic photons and UV-B falling in between (). Each component of UV can exert a variety of effects on cells, tissues and molecules.

Electromagnetic spectrum of visible and UV radiation and biologic effects on the skin. Solar UV radiation can be subdivided into UVA, UVB and UVC components, however because of atmospheric ozone that absorbs UVC, ambient sunlight is predominantly UVA (90%95%) and UVB (5%10%). UV penetrates the skin in a wavelengthdependent manner. Longer wavelength UVA penetrates deeply into the dermis reaching well into the dermis. In contrast, UVB is almost completely absorbed by the epidermis, with comparatively little reaching the dermis. UVA is efficient at generating reactive oxygen species that can damage DNA via indirect photosensitizing reactions. UVB is directly absorbed by DNA which causes molecular rearrangements forming the specific photoproducts such as cyclobutane dimers and 64 photoproducts. Mutations and cancer can result from many of these modifications to DNA.

Ambient UV exposure varies geographically according to intensity of sunlight in a particular location on Earth. Since UV radiation can be reflected, scattered and dampened by atmospheric particles, ambient UV dose varies according to the amount of atmosphere it must pass through, making UV doses higher nearest the Equator (where sunlight strikes the Earth most directly), at higher altitudes and in conditions of minimal cloud or particulate cover. Personal UV dosing depends not only on strength of solar radiation, but also on time spent outdoors occupationally or recreationally and the usage of UV-protective clothing, shade and sun blocks. Since equatorial locations tend to be warm and conducive to recreational or occupational outdoor activities, people living such locales typically wear less clothing and have more contact with ambient sunlight and usually receive much higher ambient UV doses than persons inhabiting temperate climates. Not surprisingly, skin cancer risk generally mirrors this geographic pattern, particularly among fair-skinned sun-sensitive persons [4446].

The number and use of indoor tanning salons has skyrocketed over the last several years. In America alone, only 1% of the population had ever used a tanning bed in the late 1980s. Now it is estimated that over 25% of Americans have engaged in purposeful exposure to artificial UV radiation [47]. Indoor tanning is an important industry with nearly 30 million clients, 100,000 employees and billions of dollars of annual business. Indoor tanning machines are poorly regulated and vary widely with respect to UV composition and strength. UV output from tanning beds can be up to ten times more powerful than sunlight [48,49], making the tanning bed an authentic carcinogenic instrument. Tanning can be addictive, leading to frequent and significant UV exposure over time [5052], and since tanning often appeals to adolescents and young adults, tanning patrons UV history can be significant for many years [53].

Indoor tanning clearly increases incidence of skin cancers [54,55]. With respect to melanoma, the deadliest of skin malignancies, lifetime risk increases by 75% if people engage in artificial tanning before the age of 35 years [5658]. Cancer risk increases with years of use, number of sessions, and total number of UV h exposed [54,56,59,60]. Since the molecular pathways in the skin that activate UV-induced tanning result from cellular and DNA damage which underlie skin damage and carcinogenesis (), it appears as though there is no safe use of tanning salons [57]. The tanning industry has engaged a powerful political lobby to further its commercial interests by downplaying the adverse health risks of UV. Instead, the industry publicizes the health benefits of UV to its clients, emphasizing vitamin D production which is naturally made in the skin by the chemical conversion of 7-dehydrocholesterol into vitamin D3 (cholecalciferol) after UVB exposure [6169]. In fact, UV doses that induce tanning far exceed what is required for adequate vitamin D production and the widespread availability of vitamin D in supplements and fortified foods minimizes the need for UV exposure to avoid symptoms of rickets and vitamin D deficiency [7074]. Multiple studies report overwhelming evidence that the risks of indoor tanning far outweigh potential health benefits, most significantly for malignancy. Decreasing UV radiation exposure, both naturally from sunlight and artificially from tanning bed use, may be the single best way to reduce incidence of melanoma and other skin cancers [75].

Mechanisms of the physiologic tanning response. Hormonal interactions between epidermal keratinocytes and melanocytes mediate much of the cutaneous melanization response. DNA and cellular damage in keratinocytes up-regulates transcription of the pro-opiomelanocortin (POMC) gene which encodes production and secretion of melanocyte stimulating hormone (-MSH). -MSH binding to melanocortin 1 receptor (MC1R) on melanocytes in the basal epidermis generates the second messenger cAMP via interactions between MC1R and adenylyl cyclase, and leads to activation of protein kinase A and the cAMP responsive binding element (CREB) and microphthalmia (Mitf) transcription factors. CREB and Mitf directly enhance melanin production by raising levels of tyrosinase and other melanin biosynthetic enzymes. Thus, MSH-MC1R signaling leads to enhanced pigment synthesis by melanocytes and accumulation of melanin by epidermal keratinocytes. By this mechanism, the skin is better protected against UV insults. Of note, UV-induced pigmentation may also occur through other signaling pathways as well as direct effects of UV on melanocytes, and there is some disagreement in the field over the role of epidermal MSH in the adaptive pigmentary response.

UV has many effects on skin physiology, with some consequences occurring acutely and others in a delayed manner. One of the most obvious acute effects of UV on the skin is the induction of inflammation. UVB induces a cascade of cytokines, vasoactive and neuroactive mediators in the skin that together result in an inflammatory response and causes sunburn [3,4,6,7679]. If the dose of UV exceeds a threshold damage response, keratinocytes activate apoptotic pathways and die. Such apoptotic keratinocytes can be identified by their pyknotic nuclei and are known as sunburn cells [80]. UV also leads to an increase in epidermal thickness, termed hyperkeratosis. By causing cell injury, UV induces damage response pathways in keratinocytes. Damage signals such as p53 activation profoundly alter keratinocyte physiology, mediating cell cycle arrest, activating DNA repair and inducing apoptosis if the damage is sufficiently great. Several h after UV exposure, however, and damage response signals abate, epidermal keratinocytes proliferate robustly [81], mediated by a variety of epidermal growth factors. Increased keratinocyte cell division after UV exposure leads to accumulation of epidermal keratinocytes which increases epidermal thickness. Epidermal hyperplasia protects the skin better against UV penetration [82].

Coupled with epidermal hyperkeratosis is adaptive melanization of the skin, also known as tanning [4,10,8386]. UV up-regulates production and epidermal accumulation of melanin pigment in the skin [8791]. This important physiologic response protects the skin against subsequent UV damage, and defects in this pathway are linked with cancer susceptibility. UV-mediated skin darkening is actually biphasic, with initial skin darkening occurring from redistribution and/or molecular changes to existing epidermal melanin pigments. Delayed increases in skin darkening, mediated by actual up-regulation in melanin synthesis and transfer to keratinocytes, begin several h to days after UV exposure [92,93]. Adaptive melanization is likely a complex physiologic response [4,10,83,85] involving multiple skin cell types interacting in a variety of ways () [86,94102]. UV has many other effects on the skin, including induction of an immune-tolerant or immunosuppressive state [103110] and production of vitamin D by direct conversion of 7-dehydrocholesterol into vitamin D3 (cholecalciferol) [6169]. Ambient sunlight, for the most part, is a mixture of UVA and UVB, yet each UV component may exert different and distinct effects on the skin [111,112]. UVB, for example, is a potent stimulator of inflammation and the formation of DNA photolesions (such as mutagenic thymine dimers) [112,113], whereas UVA is much less active in these measures but instead is a potent driver of oxidative free radical damage to DNA and other macromolecules [114116]. Thus, each may contribute to carcinogenesis through different mechanisms [117119]. The influence of UVA and UVB on skin physiology is an active area of investigation.

Besides promoting formation of photodimers in the genome, UV causes mutations by generating reactive oxygen species (ROS) such as superoxide anion, hydrogen peroxide and the hydroxyl radical [21] (). Nucleotides are highly susceptible to free radical injury. Oxidation of nucleotide bases promotes mispairing outside of normal Watson-Crick parameters, causing mutagenesis [120]. The transversion guaninethymine, for example, is a well-characterized mutation caused by ROS by oxidizing guanine at the 8th position to produce 8-hydroxy-2-deoxyguanine (8-OHdG) [121,122]. 8-OHdG tends to pair with an adenine instead of cytosine and therefore this oxidative change mutates a G/C pair into an A/T pair. Such mutations can be found in tumors isolated from the skin, suggesting that oxidative injury can be carcinogenic [123]. Cellular maintenance pathways exist to inactivate oxidative species as well as to repair the DNA damage they cause. The base excision repair pathway (BER) is the main molecular means by which cells reverse free radical damage in DNA to avoid oxidative mutagenesis. This pathway is initiated by damage-specific glycosylases that scan DNA for specific alterations including deaminated, alkylated or oxidized bases. After altered or inappropriate bases are recognized by a lesion-specific glycosylase, the enzyme cleaves the nucleotide base from the sugar and phosphodiesterase backbone by lysis of the N-glycosylic bond between the base and the deoxyribose. This step forms an abasic or apurinic/apyrimidinic (AP) site in the DNA, which is then processed and repaired using the complementary strand as a template to ensure fidelity.

UV generates oxidative free radicals. UV photons interact with atomic oxygen to promote formation of free radical derivatives such as superoxide, hydrogen peroxide and the highly reactive hydroxyl radical. Free radicals avidly attack macromolecules such as protein, lipid, RNA and DNA, altering their structure and interfering with their function. Detoxifying and protective enzymes such as superoxide dismutase, catalase and glutathione peroxidase detoxify and reduce levels of oxidative species in the cell.

Cells also have a complex and robust network of anti-oxidant molecules that detoxify reactive species to prevent free radical changes to DNA and other macromolecules. Glutathione (GSH) is an oligopeptide made up of three amino acids- cysteine, glycine and glutamine and is among the most important cellular antioxidant molecules. By donating electrons to otherwise reactive molecules, GSH functions as a reducing agent to neutralize reactivity of free radicals. In the process, glutathione itself becomes oxidized but can be reduced to its basal state by glutathione reductase using NADPH as an electron donor and be recycled. In any cell, therefore, glutathione can be found in both its reduced and oxidized forms and abnormalities in the ratio of reduced to oxidized glutathione can indicate oxidative stress. Catalase is another major antioxidant enzyme that detoxifies hydrogen peroxide [124126], whereas superoxide dismutases (SODs) inactivate superoxide anions [127]. Regulation of these antioxidant enzymes is a major area of investigation [128,129] since it is critical in determining cutaneous responses to UV radiation.

Besides free radical formation, UV directly affects nucleotide base pairing in DNA [130,131]. Pyrimidine bases are particularly vulnerable to chemical alteration by absorption of UV energy. Shorter-wavelength UV photons, particularly UV-B and UV-C, cleave internal 56 double bonds of pyrimidines. When this occurs between adjacent pyrimidines, abnormal covalent bonds may form and alter the three-dimensional structure of the double helix. Two major photolesions- cyclobutane pyrimidine dimers or (6,4)- photoproducts- predictably form in this way after UV exposure, and both are highly mutagenic [132]. It is estimated that one days worth of sun exposure results in up to 105 UV-induced photolesions in every skin cell [133]. UV-induced photolesions impair transcription, block DNA replication and base pair abnormally. They cause characteristic transition mutations known as UV signature mutations, for example, TTCC. The abundance of UV signature mutations in cancer-regulatory genes among many primary skin cancer isolates strongly supports UV as a cancer-causing agent [134137].

Nucleotide excision repair (NER) is an evolutionarily-conserved mechanism for repairing UV-induced photoproducts and other bulky DNA lesions [138]. The importance of NER in cancer resistance is best illustrated by considering the natural history of patients with Xeroderma Pigmentosum (XP), a rare UV hypersensitivity syndrome caused by homozygous defects in any one of at least eight required effector proteins of a common pathway that executes NER: XPA, ERCC1, ERCC3 (XP-B), XPC, ERCC2 (XP-D), DDB2 (XP-E), ERCC4 (XP-F), ERCC5 (XP-G) and POLH. XP patients demonstrate profound UV sensitivity and develop characteristic skin changes including pigmentary abnormalities, capillary telangiectasias and atrophy on UV-exposed anatomic sites at very early ages. Premalignant lesions and skin cancers develop in high frequency and much sooner than in unaffected persons. Basal cell carcinomas, squamous cell carcinomas and melanomas often develop before the second decade of life, decades before the general population [139]. Moreover, XP-associated skin cancers frequently demonstrate UV signature mutations, clearly indicating the importance of NER in the cancer resistance [140]. The NER pathway represents an orchestrated interaction of enzymes that function together to repair lesions that alter the three-dimensional structure of DNA. After recognition of damage and recruitment of a multiprotein repair complex to the damaged site, the damage strand is nicked several nucleotides away on either side of the damaged bases. The damaged region is excised and the resulting gap is filled in by a DNA polymerase using the non-damaged strand as a template [141143] (). Though only a handful of core factors are necessary and sufficient for the repair of UV-induced DNA lesions, there are numerous accessory factors that regulate this genome maintenance pathway. While the importance of NER in UV and skin cancer resistance is most clearly demonstrated by the natural history of patients with XP, attention is being paid to the role of NER polymorphisms on UV sensitivity and skin cancer incidence in sporadic populations.

UV-induced cyclobutane dimers- structure (A) and repair by the Nucleotide Excision DNA Repair (NER) pathway (B). The NER pathway is mediated by at least eight enzymes that work together to identify bulky DNA lesions that distort the structure of the double helix, excise the damaged portion and replace the excised region by DNA synthesis directed by the complementary strand. Homozygous deficiency in any one of the NER enzymes leads to the clinical condition known as Xeroderma Pigmentosum (XP). Although not shown, NER can also be initiated in actively transcribed regions of the genome by involvement of the Cockayne syndrome proteins A and B.

Skin cancers are by far the most common malignancies of humans, with well over a million cases diagnosed each year [144]. Roughly 1 in 5 Americans will develop skin cancer in their lifetime [145]. They account for nearly 15,000 deaths and more than three billion dollars each year in medical costs in the United States alone [146,147]. Like many other cancers contributed to by environmental etiologies (in this case UV), skin cancer incidence increases markedly with age presumably reflecting the long latency between carcinogen exposure and cancer formation. Skin cancers are commonly grouped into two main categories, melanoma and non-melanoma skin cancers (NMSC), based on cell of origin and clinical behavior. Risk of skin cancer is heavily influenced by UV exposure and by skin pigmentation [148] ().

Influence of pigmentation on skin cancer risk. Fair-skinned individuals with low levels of melanin in the epidermis display a UV sensitive phenotype, tending to burn rather than tan, after UV exposure. Recent data suggest that mutations that contribute to fair complexion and tanning impairment, specifically signaling defects in the melanocortin 1 receptor (MC1R), may also be associated with less efficient DNA repair in melanocytes. MC1R-defective individuals not only suffer higher realized doses of UV radiation because their skin is less able to block UV photons, but they may also accumulate more mutations from UV exposure because of defective DNA repair.

Malignant melanoma of the skin is the deadliest form of skin cancer. Thought to arise from epidermal melanocytes, melanoma is a treatment-refractory and metastasis-prone malignancy whose incidence has increased steadily and significantly over the last several decades [149]. Whereas only one in 1500 Americans was ever diagnosed with melanoma in the 1930s, now roughly one in sixty will be affected by the disease [150]. Melanoma accounts for about three quarters of all deaths from skin cancers, numbering nearly ten thousand per year in the U.S., despite accounting for far fewer than ten percent of all skin malignancies. Melanoma burden is predictably largest in places with large numbers of fair-skinned individuals living in warm, sunny climates [151]. Most melanomas arise out of pre-existing moles, therefore having many nevi is another important risk factor for the disease. If caught early, many melanomas can be managed by surgical excision alone. However, melanomas are quick to invade and metastasize and long-term survival is poor for advanced disease. Even with recent progress made in targeted therapy [152156] and immunotherapy [157,158], melanoma is notoriously difficult to treat once it has spread beyond its original site. It is not clear why melanoma incidence has increased so dramatically over the past several decades, but it is likely multifactorial, with contributions from increased UV exposure, environmental and inherited cancer risk factors and better surveillance and earlier detection [151,159172].

Non-melanomatous skin cancers greatly outnumber melanomas in incidence, but fortunately most are much easier to treat and have much better long-term prognosis. The two major forms, basal cell carcinomas and squamous cell carcinomas, are both derived from epidermal keratinocytes. They are less deadly than melanoma mainly due to their tendency to remain confined to their primary site of disease, which makes their management much more straightforward. The overwhelming majority of keratinocyte malignancies develop in the areas of skin most exposed to UV, such as on the face and arms. Most are effectively treated by local control measures alone such as resection, MOHS microsurgery or cryosurgery.

There are strong epidemiologic and molecular data linking all forms of skin cancer to UV exposure [173], and it is estimated that UV is causative for nearly 65% of melanoma and 90% of non-melanoma skin cancers [174,175]. UV-signature mutations in key cancer-relevant genes such as the p53 tumor suppressor in squamous cell carcinoma for example are well-characterized, and exome analysis of a panel of melanomas revealed strong genetic evidence for a direct mutagenic role of UV radiation in the pathogenesis of melanoma [137,176183]. Since UV-induced DNA mutations represent a major causative factor for melanoma and other skin cancers, it follows that resistance to UV-mediated mutagenesis is a critical determinant of skin cancer risk [184].

The melanocortin 1 receptor (MC1R) is a critical genetic locus involved in pigmentation, the adaptive tanning response and skin cancer susceptibility [185192]. The MC1R is found on the surface of melanocytes where it binds to -melanocyte stimulating hormone (MSH) and transmits differentiation signals into the cell through activation of adenylyl cyclase and generation of cAMP [193195]. cAMP signaling leads to activation of the protein kinase A (PKA) cascade which, in turn, leads to increased levels and/or activity of many melanogenic enzymes to enhance production and export of melanin by melanocytes [90,196,197] (). MC1R signaling also decreases UV-mediated mutagenesis by enhancing genome maintenance pathways in melanocytes [125,126,192,198]. Loss-of-signaling MC1R polymorphisms are commonly found among fair-skinned, sun-sensitive and skin cancer-prone populations (e.g., Northern Europeans). The most prevalent MC1R mutations (D84E, R151C, R160W and D294H) are commonly referred to as RHC (red hair color) alleles because of their association with red hair color, freckling and tendency to burn after UV exposure [199,200]. Loss of signaling MC1R alleles such as the RHC variants are associated with up to a four-fold increased lifetime risk of melanoma and other skin cancers [201203]. Overall, there is much evidence placing MC1R as a critical determinant of skin cancer risk, and regulation of eumelanin by POMC derived peptides depends on genetic context [204].

MC1R signaling protects the skin from UV damage by at least two major mechanisms. First, by inducing pigment synthesis in melanocytes, MC1R enhance production and accumulation of eumelanin in the epidermis. Epidermal melanization blocks penetration of UV into the skin, reducing realized doses of UV and decreasing mutagenesis and cancer risk. MC1R signaling also directly influences UV resistance of melanocytes by enhancing nucleotide excision DNA repair and oxidative resistance. Since MC1R signaling is potentially targetable by agents that influence cAMP levels [82,84,205], pharmacologic manipulation of cutaneous cAMP may be a useful approach to reduce UV sensitivity and cancer risk. Theoretically, raising cAMP levels in the skin can be accomplished either by stimulating its production (e.g., adenylyl cyclase activation) or by impeding its degradation (e.g., phosphodiesterase inhibition). Both of these approaches have been quite successful in enhancing epidermal melanin levels in animal models [84,206] and each would be expected to be effective even in individuals harboring loss-of-signaling functional mutations in MC1R. Alternatively, -MSH or agonistic MC1R peptide ligands would offer more specificity (working only on melanocytes) but might be less effective in individuals with inherited MC1R signaling defects [192,193,207].

One of the greatest risk factors for the development of cutaneous melanoma is having a fair skin complexion, which is characterized by low levels of a UV-blocking dark pigment called eumelanin in the epidermis. Individuals with light skin pigmentation suffer comparatively more skin damage from UV because it is relatively easy for UV rays to penetrate the epidermis to damage both keratinocytes and melanocytes in the deeper layers of the epidermis. Fair-skinned individuals are exposed to higher realized doses of UV radiation in the skin and UV-induced mutations, which directly contribute to melanoma and other forms of skin cancer, accumulate over time. Much UV-induced pathology, including skin cancer, can be avoided by minimizing UV exposure ().

Minimize time outdoors during peak UV h (10 am to 4 pm). Seek shade as much as possible. Be aware that sunlight bounces off reflective surfaces and can reach you even under an umbrella or tree.

Avoid getting a sunburn. More than 5 sunburns doubles risk of skin cancer.

Use sunscreens with a sun protection factor (SPF) >15. Make sure to apply repeatedly (especially with sweating or swimming) and as directed. Use sunblocks that offer protection from both UV-A and UV-B rays, and be sure to cover often-missed spots- lips, ears, around eyes, neck, scalp, hands and feet.

Wear protective clothing such as rash guards and tightly woven fabrics.

Wear a hat. Wide-brimmed hats protect head, face, ears and neck. If a baseball cap is worn, make sure to use sunscreen on ears and neck.

Wear UV-protective sunglasses

Strength of solar UV increases at high altitude and with less cloud cover. Monitor the UV Index (http://www.epa.gov/sunwise/uvindex.html) and plan accordingly.

Get Vitamin D safely by relying on diet and supplements rather than UV exposure.

Do not frequent tanning beds. They can be more dangerous than sunlight. Frequent use of artificial tanning products clearly increases risk of each of the major kinds of skin cancer, including melanoma.

Sunless self-tanning products seem safe but typically offer little sun-blocking UV protection on their own.

Examine your skin frequently, at least once a month, head to toe. Use a full-length mirror and a hand mirror to check your back, or involve a partner. Have a professional skin examination annually.

Seek professional medical attention for:

Sores that do not heal

Changes in moles (growth, irregularity, asymmetry, color changes, elevation, pain, itching)

Skin cancers are much more easily treated when caught early.

We and others are increasingly interested in heritable factors that determine melanoma risk to be able to intervene in the carcinogenic process. One of the most important alleles that influences skin cancer risk is the melanocortin 1 receptor (MC1R), whose function is central to the adaptive pigmentation (tanning) response in the skin. Besides mediating the tanning response, MC1R exerts a powerful influence on the ability of melanocytes to repair UV-induced DNA damage by the nucleotide excision DNA repair pathway. New insights into the ways in which MC1R and other genes function to protect the skin against the harmful consequences of UV may allow the rational development of pharmacologic strategies to reduce UV sensitivity and cancer risk.

The authors wish to thank current and past funding sources: the National Cancer Institute (R01 CA131075, R01 CA131075-02S1), the Wendy Will Case Cancer Research Fund, the Markey Cancer Foundation, the Childrens Miracle Network and the Jennifer and David Dickens Melanoma Research Foundation.

The authors declare no conflicts of interest.

Excerpt from:
UV Radiation and the Skin - PubMed Central (PMC)

Posted in Kentucky Stem Cells | Comments Off on UV Radiation and the Skin – PubMed Central (PMC)

Fat in the pancreas may help stave off diabetes – Medical News Today

Posted: January 20, 2022 at 2:24 am

Insulin is a hormone that the pancreas produces to regulate the amount of sugar circulating in the blood.

In diabetes, this regulatory mechanism starts to break down either when the pancreas fails to produce enough insulin or when the bodys tissues become resistant to the hormones effects.

Over time, uncontrolled high blood sugar resulting from diabetes can lead to blindness, kidney failure, strokes, and lower limb amputation.

According to the World Health Organization (WHO), in 2019, diabetes caused 1.5 million deaths worldwide.

More than 95% of people with diabetes have type 2 diabetes, which is largely the result of physical inactivity and excess body weight.

Scientists have reached a consensus that high blood sugar levels damage beta cells in the pancreas the cells that make insulin but the part that fat plays is more controversial.

Findings from a new lab-based study suggest that fat stores in the pancreas may help maintain insulin secretion and slow the onset of diabetes.

This research may provide a possible explanation for the benefits of exercise and intermittent fasting as strategies to prevent and treat type 2 diabetes.

The study indicates that a cycle of fat storage in pancreas cells after mealtimes, followed by the breakdown of fat in the hours before the next meal, may help maintain insulin production.

The research, led by scientists at the University of Geneva Medical Centre in Switzerland, appears in the journal Diabetologia.

The scientists exposed human and rat beta cells to periods of excess sugar, with or without high fat levels.

As expected, over time, high sugar levels reduced the cells ability to secrete insulin, compared with normal sugar levels.

However, an abundant supply of fat appeared to protect the beta cells insulin secretion against the effects of high sugar levels.

When cells are exposed to both too much sugar and too much fat, they store the fat in the form of droplets in anticipation of less prosperous times, Lucie Oberhauser, Ph.D., first author of the study, explains.

Surprisingly, we have shown that this stock of fat, instead of worsening the situation, allows insulin secretion to be restored to near-normal levels, she adds.

The researchers observed that periods of high fat and sugar availability, alternating with low availability, activated genes in pancreatic cells that promoted a cycle of fat storage and mobilization.

The benefits of this cycle became apparent during periods when the cells no longer had ample energy supplies.

These fasting-like conditions induced fat mobilization that supported insulin secretion, said Pierre Maechler, Ph.D., who led the study.

In other words, the whole cycle of fat storage (overnutrition) followed by fat mobilization (fasting) is required for the mechanism uncovered in our study, he told Medical News Today.

He said a fast of just 46 hours would be sufficient to allow beta cells to reset and recover their insulin-secreting capacity between meals.

Practically, avoid snacking! he advised.

He believes that the release of fat from stores is not a problem provided the body uses it as a source of energy between mealtimes for example, to fuel regular bouts of physical activity.

Other scientists have questioned whether these findings from isolated pancreas cells growing in dishes in a lab can be extrapolated to people with obesity.

[I]n truth, the higher the [body mass index], the higher the risk of diabetes, and there is evidence that excess fat deposition in key organs, such as [the] liver and pancreas, accelerates diabetes risks, said Naveed Sattar, Ph.D., professor of metabolic medicine at the University of Glasgow in the United Kingdom.

There is plentiful evidence high circulating triglycerides, which deliver excess fat to [the] pancreas, may accelerate diabetes risk, he told MNT.

Triglycerides are a type of fat that the body uses as fuel.

Prof. Sattar cited a clinical trial in which he was involved and which suggests that raised levels of fat in the pancreas contribute to the dysfunction of beta cells.

The Diabetes Remission Clinical Trial shows that when people recover from diabetes as a result of weight loss, their long-term remission depends on continuing low levels of triglycerides in their bloodstream and low levels of fat in their pancreas.

Dr. Francesco Rubino, chair of Metabolic and Bariatric Surgery at Kings College London in the U.K., also cautioned that the new lab-based study may not reflect what happens in the body.

He told the Science Media Centre (SMC) in London that type 2 diabetes involves problems with other tissues and organs, not just the pancreas. For example, experts associate excess fat with widespread insulin resistance and inflammation.

Hence, it is difficult to assess the clinical relevance of the observations from this study and, specifically, the potential role of fat as protective for the development of diabetes as suggested by the authors, he said.

However, he pointed out that, while the association between excess fat and diabetes is clear, the nature of the association is less obvious.

Katarina Kos, M.D., Ph.D., senior lecturer and honorary consultant physician in diabetes and endocrinology at the University of Exeter Medical School in the U.K., told the SMC:

It would be wrong to take from this study that fat rescues the pancreatic insulin-secreting cell once damaged. Reduced nutritional intake combined with exercise improves insulin sensitivity, and this remains the key recommendation for prevention and treatment of type 2 diabetes.

More:
Fat in the pancreas may help stave off diabetes - Medical News Today

Posted in Diabetes | Comments Off on Fat in the pancreas may help stave off diabetes – Medical News Today

Diabetes Disparities: Where You Live Impacts Long-Term Health – AARP

Posted: January 20, 2022 at 2:24 am

We found significant differences in the rates of D5 attainment both by rurality and deprivation, she said.

Specifically, they found:

McCoy says that anyone living withdiabetesshould have access to a trusted health care provider who can help them meet the D5 metrics safely.

It is important to work closely with their health care providers to optimize blood glucose,blood pressureand cholesterol management; not smoke or use other tobacco products; and take aspirin if they have existing heart disease, she said.

Communication is key. Patients should tell their health care provider if they can afford and tolerate their medications, and discuss any other barriers to diabetes care, she said.

There are resources available to help people living with diabetes afford medications and testing supplies, and to live well with their diabetes. Pharmacists, certified diabetes care and education specialists, community health workers, community paramedics and social workers are all integral parts of the health care team and can help people living with diabetes, McCoy said.

For older adults with diabetes, McCoy suggests they select aMedicareAdvantage or Part D plan that covers the medications they need to manage their diabetes. She also cautions them to be particularly watchful of experiencing hypoglycemia (low blood sugar) or hypotension (low blood pressure).

Older people are particularly susceptible to both, and both are dangerous. If they are, they need to tell their health care provider so their regimens can be changed. It is important for blood glucose and blood pressure to be in a safe range, not too high or too low, McCoy said.

Peter Urban is a contributing writer and editor who focuses on health news. Urban spent two decades working as a correspondent in Washington, D.C., for daily newspapers in Connecticut, Massachusetts, Ohio, California and Arkansas, including a stint as Washington bureau chief for theLas Vegas Review-Journal.His freelance work has appeared inScientific American, Bloomberg Governmentand CTNewsJunkie.com.

View post:
Diabetes Disparities: Where You Live Impacts Long-Term Health - AARP

Posted in Diabetes | Comments Off on Diabetes Disparities: Where You Live Impacts Long-Term Health – AARP

Nanotherapy Offers New Hope for the Treatment of Type 1 Diabetes – Laboratory Equipment

Posted: January 20, 2022 at 2:24 am

Individuals living with Type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without viable long-term treatments, this course of treatment is a lifelong sentence.

Pancreatic islets control insulin production when blood sugar levels change, and in Type 1 diabetes, the bodys immune system attacks and destroys such insulin-producing cells. Islet transplantation has emerged over the past few decades as a potential cure for Type 1 diabetes. With healthy transplanted islets, Type 1 diabetes patients may no longer need insulin injections, but transplantation efforts have faced setbacks as the immune system continues to eventually reject new islets. Current immunosuppressive drugs offer inadequate protection for transplanted cells and tissues and are plagued by undesirable side effects.

Now a team of researchers at Northwestern University has discovered a technique to help make immunomodulation more effective. The method uses nanocarriers to re-engineer the commonly used immunosuppressant rapamycin. Using these rapamycin-loaded nanocarriers, the researchers generated a new form of immunosuppression capable of targeting specific cells related to the transplant without suppressing wider immune responses.

Thepaper was publishedin the journal Nature Nanotechnology. The Northwestern team is led byEvan Scott, associate professor of biomedical engineeringandGuillermo Ameer, professor of biomedical engineering at McCormick and Surgery at Feinberg. Ameer also serves as the director of theCenter for Advanced Regenerative Engineering (CARE).

Ameer has been working on improving the outcomes of islet transplantation by providing islets with an engineered environment, using biomaterials to optimize their survival and function. However, problems associated with traditional systemic immunosuppression remain a barrier to the clinical management of patients and must also be addressed to truly have an impact on their care, said Ameer.

This was an opportunity to partner with Evan Scott, a leader in immunoengineering, and engage in a convergence research collaboration that was well executed with tremendous attention to detail by Jacqueline Burke, a National Science Foundation Graduate Research Fellow, Ameer said.

Rapamycin is well-studied and commonly used to suppress immune responses during other types of treatment and transplants, notable for its wide range of effects on many cell types throughout the body. Typically delivered orally, rapamycins dosage must be carefully monitored to prevent toxic effects. Yet, at lower doses it has poor effectiveness in cases such as islet transplantation.

Scott, also a member of CARE, said he wanted to see how the drug could be enhanced by putting it in a nanoparticle and controlling where it goes within the body.

To avoid the broad effects of rapamycin during treatment, the drug is typically given at low dosages and via specific routes of administration, mainly orally, Scott said. But in the case of a transplant, you have to give enough rapamycin to systemically suppress T cells, which can have significant side effects like hair loss, mouth sores and an overall weakened immune system.

Following a transplant, immune cells, called T cells, will reject newly introduced foreign cells and tissues. Immunosuppressants are used to inhibit this effect but can also impact the bodys ability to fight other infections by shutting down T cells across the body. But the team formulated the nanocarrier and drug mixture to have a more specific effect. Instead of directly modulating T cells the most common therapeutic target of rapamycin the nanoparticle would be designed to target and modify antigen presenting cells (APCs) that allow for more targeted, controlled immunosuppression.

Using nanoparticles also enabled the team to deliver rapamycin through a subcutaneous injection, which they discovered uses a different metabolic pathway to avoid extensive drug loss that occurs in the liver following oral administration. This route of administration requires significantly less rapamycin to be effective about half the standard dose.

We wondered, can rapamycin be re-engineered to avoid non-specific suppression of T cells and instead stimulate a tolerogenic pathway by delivering the drug to different types of immune cells? Scott said. By changing the cell types that are targeted, we actually changed the way that immunosuppression was achieved.

The team tested the hypothesis on mice, introducing diabetes to the population before treating them with a combination of islet transplantation and rapamycin, delivered via the standard Rapamune oral regimen and their nanocarrier formulation. Beginning the day before transplantation, mice were given injections of the altered drug and continued injections every three days for two weeks.

The team observed minimal side effects in the mice and found the diabetes was eradicated for the length of their 100-day trial; but the treatment should last the transplants lifespan. The team also demonstrated the population of mice treated with the nano-delivered drug had a robust immune response compared to mice given standard treatments of the drug.

The concept of enhancing and controlling side effects of drugs via nanodelivery is not a new one, Scott said. But here were not enhancing an effect, we are changing it by repurposing the biochemical pathway of a drug, in this case mTOR inhibition by rapamycin, we are generating a totally different cellular response.

The teams discovery could have far-reaching implications. This approach can be applied to other transplanted tissues and organs, opening up new research areas and options for patients, Ameer said. We are now working on taking these very exciting results one step closer to clinical use.

Jacqueline Burke, the first author on the study and a National Science Foundation Graduate Research Fellow and researcher working with Scott and Ameer at CARE, said she could hardly believe her readings when she saw the mices blood sugar plummet from highly diabetic levels to an even number. She kept double-checking to make sure it wasnt a fluke, but saw the number sustained over the course of months.

For Burke, a doctoral candidate studying biomedical engineering, the research hits closer to home. Burke is one such individual for whom daily shots are a well-known part of her life. She was diagnosed with Type 1 diabetes when she was nine, and for a long time knew she wanted to somehow contribute to the field.

At my past program, I worked on wound healing for diabetic foot ulcers, which are a complication of Type 1 diabetes, Burke said. As someone whos 26, I never really want to get there, so I felt like a better strategy would be to focus on how we can treat diabetes now in a more succinct way that mimics the natural occurrences of the pancreas in a non-diabetic person.

The all-Northwestern research team has been working on experiments and publishing studies on islet transplantation for three years, and both Burke and Scott say the work they just published could have been broken into two or three papers. What theyve published now, though, they consider a breakthrough and say it could have major implications on the future of diabetes research.

Scott has begun the process of patenting the method and collaborating with industrial partners to ultimately move it into the clinical trials stage. Commercializing his work would address theremaining issuesthat have arisen for new technologies likeVertexs stem-cell derived pancreatic isletsfor diabetes treatment.

Republished courtesy of Northwestern University.Photo credit: Northwestern University.

Read more:
Nanotherapy Offers New Hope for the Treatment of Type 1 Diabetes - Laboratory Equipment

Posted in Diabetes | Comments Off on Nanotherapy Offers New Hope for the Treatment of Type 1 Diabetes – Laboratory Equipment

Living with diabetes: U of A Exhibit shows a diabetic’s daily struggles – KGUN

Posted: January 20, 2022 at 2:24 am

TUCSON, Ariz. (KGUN) Across the country, one in ten people were told they had diabetes in 2020 and a few years before, diabetes was the seventh leading cause of death in the United States.

According to the Arizona Department of Health Services about 600,000 people have type 2 diabetes and about 1,800 youth are diagnosed with type 1, both creating daily struggles for them and their families.

Over at the University of Arizona, there is a new exhibit in the health sciences library that is helping depict the day in the life for those with diabetes called Strips and Needles: A Day in the Life".

"My goal for the exhibit strips and needles is to serve a whole host of communities," Dr. Michael Lee Zirulnik, the exhibit's creator and type 1 diabetic, said. "To serve medical and allied health students, to serve families, to let families know that beauty can come out of things that are a challenge, and for people that have a hidden or visible disabilities, whether it's diabetes or something else."

Zirulnik cataloged over 3,000 test strips and insulin syringe needles into the panels of the exhibit, showcasing a full year of daily struggles for diabetics.

The Diabetes Prevention Program is a year long support group that helps those suffering with type 2 learn to create healthy lifestyle choices. The program's state director Vanessa da Silva said from stress management to a healthy diet, there are ways to help with type 2.

She said when someone is both chronically or acutely stressed, their blood sugar spikes, which is even more prevalent due to the pandemic.

"Theyre also reporting that for those that have had COVID and the worse the infection is the higher the risk is for diabetes, type 1 or type 2," she said. "Our diabetes risk is higher in certain populations that are lower economic status, a hispanic/latino, or tribal, of which we have a lot here in Arizona.

----

STAY IN TOUCH WITH US ANYTIME, ANYWHERE

More:
Living with diabetes: U of A Exhibit shows a diabetic's daily struggles - KGUN

Posted in Diabetes | Comments Off on Living with diabetes: U of A Exhibit shows a diabetic’s daily struggles – KGUN

St. Mary’s Hospital team finds new link between lung function and diabetes – Korea Biomedical Review

Posted: January 20, 2022 at 2:24 am

Two researchers at Seoul St. Mary's Hospital released a study result on Tuesday, which stresses the need for people with poor lung function to monitor their health, especially the possibility of diabetes closely.

Diabetes mellitus is a systemic inflammatory disease in which high blood sugar persists for a long time. Prior studies have shown a decrease in lung capacity due to chronic inflammation in diabetic patients. In addition, researchers have published studies on diabetes in patients with chronic airway diseases such as asthma or chronic obstructive pulmonary disease.

However, few studies analyzed the association between lung function and the development of diabetes by following up on undiagnosed adults for years.

The research team, led by Professors Kim Hun-sung of the Department of Endocrinology and Lee Hwa-young of the Department of Allergy and Clinical Immunology, analyzed and compared diabetes development and lung function in 17,568 healthy adults who received a health checkup at the hospital from March 2009 to October 2012. They had not had diabetes and received at least two lung function tests in six years.

Among them, 152 (0.9 percent) had diabetes, and the team performed a multiple logistic regression analysis to determine the relationship between diabetes onset and multiple variables.

After adjusting for age, gender, and body mass index, the team found that the group with a forced expiratory volume in one second and forced vital capacity (FEV1/FVC) ratio of 78-82 percent had a 40 percent lower risk of diabetes than the group with an FEV1/FVC ratio of 86 percent or higher.

The FEV1/FVC ratio represents airway resistance, and the team identified it as a predictor of future diabetes incidence in healthy adults.

By analyzing the correlation between pulmonary function and glycated hemoglobin followed for six years in the same person, the team also confirmed a negative correlation -- lower the pulmonary function test value led to higher glycated hemoglobin.

The research team said the study is significant. It analyzed the blood test results, including the six-year follow-up lung function, clinical characteristics, and glycated hemoglobin of non-diabetic patients with large-scale data.

Through this study, the research team found that decreased lung function and airway resistance are related to blood sugar and lungs and that managing lung health will help prevent diabetes.

Endocrinology and Metabolism published the results of the study in its December issue.

More here:
St. Mary's Hospital team finds new link between lung function and diabetes - Korea Biomedical Review

Posted in Diabetes | Comments Off on St. Mary’s Hospital team finds new link between lung function and diabetes – Korea Biomedical Review

Reverse pre-diabetes with diet, pro tips to ease you into the process – Times Now

Posted: January 20, 2022 at 2:24 am

Updated Jan 20, 2022 | 12:31IST

Experts say that making a few changes in your routine and being consistent with those habits can help you reverse prediabetes and achieve normal blood sugar levels, which is anything less than 140 mg/dL (7.8 mmol/L).

Several studies have shed light on how an early breakfast and timely dinner are linked to lower risk of insulin resistance a major contributor to diabetes risk.   |  Photo Credit: iStock Images

New Delhi: Pre-diabetes is a state when the blood sugar levels are high enough to be a cause of concern, yet not high enough to be diagnosed as diabetes. Although an unpleasant diagnosis, the best part about pre-diabetes is that it is a reversible state all you need to do is practice a few dietary changes and get ample workouts. When an individuals blood sugar levels cross the 8 A1C mark, he or she is considered diabetic. However, when blood sugar levels range from 140 to 199 mg/dL (7.8 to 11.0 mmol/L), the state is known as pre-diabetes.

Fret not, experts say that making a few changes in your routine and being consistent with those habits can help you reverse prediabetes and achieve normal blood sugar levels, which is anything less than 140 mg/dL (7.8 mmol/L). Take a look at ourtips to reverse pre-diabetes without medication.

Disclaimer: Tips and suggestions mentioned in the article are for general information purposes only and should not be construed as professional medical advice. Always consult your doctor or a dietician before starting any fitness programme or making any changes to your diet.

Get the Latest health news, healthy diet, weight loss, Yoga, and fitness tips, more updates on Times Now

See more here:
Reverse pre-diabetes with diet, pro tips to ease you into the process - Times Now

Posted in Diabetes | Comments Off on Reverse pre-diabetes with diet, pro tips to ease you into the process – Times Now

Diabetes Advocacy Orgs: 2022 Goals After Another Tough Year – Healthline

Posted: January 20, 2022 at 2:24 am

We have a longstanding tradition here at DiabetesMine to query prominent diabetes advocacy organizations at the start of each new year about their past-year accomplishments and goals for the year ahead.

Much like the year before, 2021 was a difficult one, dominated by the COVID-19 pandemic impacting our lives and the diabetes community in so many ways. Heres what five of the most well-known diabetes nonprofit orgs are currently telling us about milestones and what they hope to accomplish soon.

This is of course not an exhaustive list of groups involved in diabetes advocacy, but these five stand out as some of the largest and most influential representing type 1 diabetes (T1D) here in the United States.

Former CEO Tracey D. Brown announced her resignation in mid-2021 and left the org in October 2021.

During the search for a new chief exec, three internal ADA leaders Scientific and Medical Officer Dr. Robert Gabbay, Chief of Development Officer Charles Henderson, and Chief Financial Officer Charlotte Carter formed an interim Office of the CEO to ensure a smooth transition period.

There is no timeline on when that search may be complete, but its highly likely the ADA will name a new CEO prior to their big annual Scientific Sessions conference scheduled for June 3 to 7, 2022. The org has already announced that it plans to hold a hybrid virtual and in-person event, as it did in both 2021 and 2020 because of the COVID-19 pandemic. This summers in-person event will take place in New Orleans, Louisiana.

As to 2021 highlights and 2022 plans, an organization spokeswoman told DiabetesMine it will prioritize 6 advocacy areas in the year ahead:

As the longest-running and largest organization dedicated to type 1 diabetes (T1D) research, advocacy and support, the JDRF has a number of efforts planned for 2022 that take into consideration its work during the past year.

In response to DiabetesMines inquiry about JDRF highlights in 2021, an organization spokesperson calls out the orgs work advocating on a number of different fronts from Congressional meetings, FDA regulatory advocacy on new technology and medications, big research funding efforts on treatments and tech, and federal legislative efforts on the Build Back Better plan proposing a $35 insulin copay cap for all federal employer-covered plans, Medicare and Marketplace Exchange plans. The JDRF updated its Health Insurance Guide with timely and relevant information in English and Spanish, to help people find information on affording insulin and diabetes supplies and other insurance topics tailored for the T1D community.

Additionally, the JDRF advocated for COVID-19 vaccine prioritization policies in 2021 and were one of the many groups pushing the CDC to include T1D in the same high-risk category as T2D in over 25 states. This advocacy work helped lead all remaining states to eventually follow suit.

These are the JDRFs priorities for 2022, per the organization:

This California-based organization was marked by tragedy at the end of 2021, as CEO Thom Scher suddenly and unexpectedly passed away in early December. Scher did not live with diabetes himself, but was a passionate advocate who had a bold vision to challenge the status quo in terms of what a nonprofit organization could do. He had been at the helm of the organization since the beginning of 2019 (see DiabetesMines interview with him here.)

As a new leader is being selected by the groups board, theyve named Arizona D-Mom Tracey McCarter as interim CEO. Shes been Involved with BT1 since its inception and on the governing board for several years. Her 4-year-old daughter Charlize was diagnosed with T1D in 2009.

All of us at Beyond Type 1 are touched by the outpouring of support weve received since Thoms passing, McCarter told DiabetesMine. We know that, together, well continue his legacy of collaboration for the greater good of the entire diabetes community. In 2022, we look forward to growing our programs, partnerships, and platforms, further uniting the global diabetes community, and providing resources and solutions that improve the lives of those impacted by diabetes. In everything we do, the memory of Thom will serve as our guiding light.

As to its 2021 achievements, the organization shared this blog post that summarized its efforts during the year and pointed to efforts to make connections worldwide, expanding its international reach, addressing language barriers, and much more.

One highlight involved launching a new Advocacy Portal, which focuses on both federal and state legislative priorities, including insulin pricing and copay caps.

For 2022, BT1 tells DiabetesMine they have many plans for the year but in particular theyre looking forward to the following:

In 2021, ADCES focused on maximizing its advocacy efforts in the virtual environment and reaching out to the new Biden Administration and members of the 117th Congress.

A spokesperson explains:

We worked with our congressional champions and activated our grassroots network to reintroduce and promote the Expanding Access to DSMT Act in the U.S. Senate (S. 2203) in June and in the U.S. House of Representatives (H.R. 5804) in November. This legislation would make necessary improvements to the Medicare benefit for diabetes self-management, education and support, referred to by Medicare as DSMT.

On the regulatory and payment front, ADCES worked with the Diabetes Technology Access Coalition (DTAC) and other partners to make changes to the Medicare local coverage determination (LCD) for CGMs. Thanks to those efforts, the LCD was updated effective July 18, 2021, to remove the requirement that Medicare beneficiaries check their blood glucose 4 times per day to be eligible for a CGM and changed language around injecting insulin to administering insulin to account for inhaled insulin products.

In addition to our involvement with DTAC, ADCES also serves as a co-chair of the Diabetes Advocacy Alliance (DAA). This year, the DAA conducted extensive outreach to the Biden Administration and met with top officials including CMS Administrator Chiquita Brooks-LaSure and Elizabeth Fowler, PhD, deputy administrator and director of the Center for Medicare and Medicaid Innovation, to discuss the DSMT benefit and Medicare Diabetes Prevention Program.

As the year comes to a close, we await the public release of the National Clinical Care Commissions final report to Congress. This report is expected to contain recommendations regarding improvements to federal diabetes policy advocated for by ADCES and other advocacy partners in the diabetes community.

This global advocacy group based in the United Kingdom is focused on the #insulin4all movement to improve access and affordability for those who use insulin, particularly in the United States where outrageously high prices are at crisis levels. DiabetesMine reached out to founder and fellow type 1 Elizabeth Pfiester about her organizations work in 2021 and plans for 2022.

She pointed to the groups top 2021 accomplishments that include the following:

For the coming year, Pfiester says, Our efforts will be focused on continuing to train and support our advocates to reach their local goals, while coordinating on a federal U.S. and global level to lower the cost of insulin and supplies.

T1International notes that it hopes for tangible outcomes will come from the Compact moving forward into 2022, saying that we continue to encourage the WHO to do this, and are part of various consultation groups to hold them accountable and work with them to improve the lives of people with diabetes.

No doubt, theres a lot to look forward to in 2022 on the insulin affordability and access front and beyond. Heres hoping for a brighter, and ideally productive, new year.

Read more:
Diabetes Advocacy Orgs: 2022 Goals After Another Tough Year - Healthline

Posted in Diabetes | Comments Off on Diabetes Advocacy Orgs: 2022 Goals After Another Tough Year – Healthline

Page 530«..1020..529530531532..540550..»